Julian S. Gangolli

Companies

• Outlook Therapeutics, Inc.Board member Apr 21, 2020 to now¹
• Krystal Biotech, Inc.Board member Mar 6, 2019 to now²
• Revance Therapeutics, Inc.Board member Jul 6, 2016 to Feb 6, 2025³
• Allergan plcCVP & Pres, North America Oct 11, 2011 to Mar 19, 2015⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RTRevance Therapeutics, Inc.0 shares⁵Feb 6, 2025
• KBKrystal Biotech, Inc. KRYS0 shares⁶May 20, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 6, 2025Returned to company 15,000 shares of Revance Therapeutics, Inc.⁵
• Feb 4, 2025U 30,106 shares at $3.65 of Revance Therapeutics, Inc.⁵
• May 20, 2024Sold 1,980 shares at $165.76 of Krystal Biotech, Inc.⁶
• May 20, 2024Sold 7,090 shares at $164.34 of Krystal Biotech, Inc.⁶
• May 20, 2024Sold 10,930 shares at $163.71 of Krystal Biotech, Inc.⁶
• May 20, 2024Exercised options 20,000 shares at $22.75 of Krystal Biotech, Inc.⁶
• May 1, 2024Granted 15,000 shares of Revance Therapeutics, Inc.⁷
• May 3, 2023Granted 3,534 shares of Revance Therapeutics, Inc.⁸
• May 4, 2022Granted 6,059 shares of Revance Therapeutics, Inc.⁹